Concert sets IPO terms

Concert Pharmaceuticals Inc. (Lexington, Mass.) amended its IPO and said it now plans to sell 5 million shares at $12-$14. At the $13 midpoint, the company -- which is seeking to list on NASDAQ -- would raise $65 million and be valued at $210.8 million. The company filed to raise up to $74.8 million in the offering last month. UBS; Wells Fargo; JMP Securities; and Roth Capital Markets are underwriters. ...